Attenuated neurotoxicity after repeated methamphetamine binges linked to dopamine transporter (DAT) decline

Area of Science:

• Neuroscience
• Toxicology
• Pharmacology

Background:

• Methamphetamine (METH) abuse is a global health concern.
• METH neurotoxicity, particularly to dopaminergic neurons, is linked to Parkinson's disease risk.
• The effects of repeated METH binge consumption on neurotoxicity markers are not fully understood.

Purpose of the Study:

• To investigate the impact of a repeated binge-like METH administration on dopaminergic neurons and neurotoxicity markers in mice.
• To assess the development of tolerance to METH-induced neurotoxicity.

Main Methods:

• Mice were subjected to a repeated binge-like METH regimen (three doses over 6 hours, repeated three times with 14-day intervals).
• Evaluated spontaneous motor activity, dopaminergic cell bodies (nigral), axon terminal damage (striatal silver staining), and dopaminergic markers (tyrosine hydroxylase, vesicular monoamine transporter 2, dopamine transporter).
• Monitored neuroinflammation (microglial and astroglial responses) and temperature changes.

Main Results:

• The first METH binge caused significant motor activity decrease, nigral dopaminergic cell loss (25%), and axon terminal damage.
• Subsequent binges showed reduced motor activity impact and minimal additional cell degeneration, indicating tolerance.
• Dopaminergic markers were depleted, with partial recovery between binges, but dopamine transporter (DAT) remained significantly reduced (25%) after the third binge.
• Neuroinflammation, including microglial and astroglial responses, and temperature changes were observed.

Conclusions:

• Repeated METH binge consumption leads to initial neurotoxicity and dopaminergic neuron loss, followed by the development of tolerance.
• Partial recovery of some dopaminergic markers occurs, but DAT shows limited recovery.
• Reduced DAT levels after the initial binge may mitigate subsequent METH neurotoxicity by limiting drug entry into neurons.